ABSTRACT
Maternal immune dysregulation seems to affect fetal or postnatal immune development. Preeclampsia is a pregnancy-associated disorder with an immune basis and is linked to atopic disorders in offspring. Here we show reduction of fetal thymic size, altered thymic architecture and reduced fetal thymic regulatory T (Treg) cell output in preeclamptic pregnancies, which persists up to 4 years of age in human offspring. In germ-free mice, fetal thymic CD4+ T cell and Treg cell development are compromised, but rescued by maternal supplementation with the intestinal bacterial metabolite short chain fatty acid (SCFA) acetate, which induces upregulation of the autoimmune regulator (AIRE), known to contribute to Treg cell generation. In our human cohorts, low maternal serum acetate is associated with subsequent preeclampsia, and correlates with serum acetate in the fetus. These findings suggest a potential role of acetate in the pathogenesis of preeclampsia and immune development in offspring.
Subject(s)
Acetates/blood , Fetus/immunology , Pre-Eclampsia/immunology , Prenatal Exposure Delayed Effects/immunology , T-Lymphocytes, Regulatory/immunology , Acetates/administration & dosage , Acetates/immunology , Acetates/metabolism , Adult , Animals , Animals, Newborn , Case-Control Studies , Child Development , Child, Preschool , Dietary Supplements , Female , Fetus/cytology , Fetus/diagnostic imaging , Gastrointestinal Microbiome/immunology , Germ-Free Life/immunology , Humans , Immune Tolerance/immunology , Infant , Infant, Newborn , Longitudinal Studies , Maternal-Fetal Exchange/immunology , Mice , Organ Size/immunology , Pre-Eclampsia/blood , Pre-Eclampsia/diagnosis , Pregnancy , Prenatal Exposure Delayed Effects/pathology , Prenatal Exposure Delayed Effects/prevention & control , Prospective Studies , Thymus Gland/cytology , Thymus Gland/diagnostic imaging , Thymus Gland/growth & development , Thymus Gland/immunology , Transcription Factors/immunology , Transcription Factors/metabolism , Ultrasonography, Prenatal , Young Adult , AIRE ProteinABSTRACT
BACKGROUND: The impairment of immune functions associated with malnutrition may be one reason for the high mortality in children with severe acute malnutrition (SAM), and thymus atrophy has been proposed as a marker of this immunodeficiency. The aim of this study was to identify nutritional and clinical correlates of thymus size in children with SAM, and predictors of change in thymus size with nutritional rehabilitation. METHODS: In an observational study among children aged 6-59 months admitted with SAM in Uganda, we measured thymus area by ultrasound on hospital admission to treatment with F75 and F100, on hospital discharge and after 8 weeks of nutritional rehabilitation with ready-to-use therapeutic food, as well as in well-nourished healthy children. We investigated anthropometric, clinical, biochemical and treatment-related correlates of area and growth of the thymus. RESULTS: Eighty-five children with SAM with a median age of 16.5 months were included. On admission 27% of the children had a thymus undetectable by ultrasound. Median thymus area was 1.3 cm2 in malnourished children, and 3.5 cm2 in healthy children (p < 0.001). Most anthropometric z-scores, hemoglobin and plasma phosphate correlated positively with thymus area. Thymus area correlated negatively with caretaker-reported severity of illness, plasma α-1 acid glycoprotein, and C-reactive protein >5 mg/L. At follow-up after 8 weeks, median thymus area had increased to 2.5 cm2 (p < 0.001). Increase in thymus area during treatment was associated with simultaneous increase in mid-upper-arm circumference, with 0.29 cm2 higher increase in thymus area per cm larger increment in MUAC (p = 0.03). Children whose F-75 had partially been replaced by rice porridge during their hospital admission had less increase in thymus area after 8 weeks. CONCLUSION: Malnutrition and inflammation are associated with thymus atrophy, and thymus area seems positively associated with plasma phosphate. Substituting therapeutic formula with unfortified rice porridge with the aim of alleviating diarrhea may impair regain of thymus size with nutritional rehabilitation. This calls for research into possible effects of phosphate status on thymus size and other immunological markers. TRIAL REGISTRATION: The study is based on data from the FeedSAM study, ISRCTN55092738 .
Subject(s)
Nutrition Therapy/methods , Severe Acute Malnutrition/pathology , Thymus Gland/pathology , Atrophy , Case-Control Studies , Child, Preschool , Female , Follow-Up Studies , Hospitalization , Humans , Infant , Male , Organ Size , Severe Acute Malnutrition/diagnostic imaging , Severe Acute Malnutrition/immunology , Severe Acute Malnutrition/rehabilitation , Thymus Gland/diagnostic imaging , Thymus Gland/immunology , Treatment Outcome , Uganda , UltrasonographyABSTRACT
PURPOSE: To report five cases of patients diagnosed with differentiated thyroid carcinoma (DTC) with uptake in the thymic area after high-dose treatment with I-131 and to evaluate the potential causes and therapeutic management. METHODS: Five cases of young female patients with a mean age of 36.6 years (24-43) who had been treated with a mean dose of 106 mCi of I-131 (100-150 mCi) showing tracer uptake in the thymic area are reported. An I-131 whole-body scan (131I-WBS) was performed 7 days after therapeutic dose administration to each patient. Anterior and posterior planar images, followed by SPECT/CT of the head, neck and superior mediastinum were acquired in all patients. Thyroglobulin levels were measured with and without hormone replacement therapy in all cases. Samples taken from the superior mediastinum were sent to pathology for analysis, which confirmed the presence of thymic tissue. RESULTS: Two patients underwent elective total thymectomy due to the gross characteristics of the gland, local 131-I uptake, and high thyroglobulin levels. The remaining three patients had already undergone thymectomy as part of neck dissection during initial surgery, and no further invasive interventions were therefore performed. Pathological examination revealed no metastases in these five patients. CONCLUSIONS: Thymus visualization in young patients after administration of therapeutic doses of I-131 seems to be a more common finding than usually thought. Absence of metastasis in the thymus despite high thyroglobulin levels was confirmed in all cases. Based on these results, we suggest that a more expectant and less aggressive therapeutic approach could be used. We also suggest that I-131 therapy for DTC should be considered in classification of the potential causes of true thymic hyperplasia in the subgroup of patients recovering from a stressor.
Subject(s)
Adenocarcinoma, Follicular/radiotherapy , Iodine Radioisotopes/therapeutic use , Radiopharmaceuticals/therapeutic use , Thymus Gland/diagnostic imaging , Thymus Hyperplasia/diagnostic imaging , Thyroid Neoplasms/radiotherapy , Adenocarcinoma, Follicular/diagnosis , Adenocarcinoma, Follicular/surgery , Adult , Female , Humans , Lymphatic Metastasis , Neck Dissection , Thymectomy , Thymus Gland/pathology , Thymus Hyperplasia/etiology , Thymus Hyperplasia/surgery , Thyroglobulin/blood , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/surgery , Tomography, Emission-Computed, Single-Photon , Whole Body Imaging , Young AdultABSTRACT
AIM: The aim was to assess the impact of nutritional status and environmental exposures on infant thymic development in the rural Matlab region of Bangladesh. METHODS: In a cohort of N(max) 2094 infants born during a randomized study of combined interventions to improve maternal and infant health, thymic volume (thymic index, TI) was assessed by ultrasonography at birth and at 8, 24 and 52 weeks of age. Data on birth weight, infant anthropometry and feeding status were also collected. RESULTS: At all ages, TI was positively associated with infant weight and strongly associated with the month of measurement. Longer duration of exclusive breastfeeding resulted in a larger TI at 52 weeks. TI at birth and at 8 weeks correlated positively with birth weight, but by 24 and 52 weeks and when adjusted for infant weight this effect was no longer present. Thymic size was not affected by pre-natal maternal supplementation or by socioeconomic status but was correlated to arsenic exposure during pregnancy. CONCLUSION: In this population of rural Bangladeshi infants, thymic development is influenced by both nutritional and environmental exposures early in life. The long-term functional implications of these findings warrant further investigation.
Subject(s)
Body Weight , Child Development/physiology , Infant Nutritional Physiological Phenomena , Thymus Gland/growth & development , Analysis of Variance , Arsenic/urine , Bangladesh , Breast Feeding , Dietary Supplements , Environmental Exposure , Female , Health Promotion/methods , Humans , Infant , Infant, Newborn , Maternal Exposure , Maternal Nutritional Physiological Phenomena , Nutritional Status , Organ Size , Pregnancy , Regression Analysis , Rural Health , Seasons , Thymus Gland/diagnostic imaging , UltrasonographyABSTRACT
OBJECTIVE: The American consensus statement on patients with low-risk thyroid cancer, published in 2003, suggests repeat (131)I therapy if the thyroglobulin value is elevated at first follow-up. We evaluated this strategy in our practice. METHODS: Among 407 patients with thyroid cancer who had total thyroidectomy and (131)I ablation between January 2000 and December 2003, 12 patients with stage I thyroid cancer (any tumour (T), any node (N), metastasis (M)0 if < 45 years or T1, N0, M0 if > 45 years), were re-treated on the basis of their thyroglobulin level at first follow-up. Mean patient age was 32.8 years. None of them had a T4 tumour. Thyroglobulin levels after thyroid hormone withdrawal 'off-T4' ranged between 4.5 and 251 ng/ml (median 8). One to four courses of 3.7 GBq (131)I were given. RESULTS: Three patients had a negative (131)I therapy scan and an uneventful course. Two patients had slight residual uptake only in the thyroid bed and negative ultrasound examination. Four patients had isolated (131)I uptake in the mediastinal region. No abnormalities were found on complementary mediastinal imaging. This finding was interpreted as benign (131)I thymic uptake. The last three patients also had mediastinal thymic uptake associated with a slight thyroid bed uptake. One patient had a gradual increase in the thyroglobulin level, and underwent resection of nonfunctioning neck lymph nodes. Thyroglobulin levels declined in all other patients. CONCLUSIONS: No distant lesions were found in a group of young 'low-risk' thyroid cancer patients given empirical (131)I therapy for residual thyroglobulin. When blind (131)I therapy shows no uptake, or uptake limited to the thymus, (131)I therapy should not be repeated. The authors also briefly discuss the hypothesis that enhanced thymus might be a source of benign thyroglobulin secretion.
Subject(s)
Carcinoma, Papillary/blood , Carcinoma, Papillary/radiotherapy , Patient Selection , Thyroglobulin/blood , Thyroid Neoplasms/blood , Thyroid Neoplasms/radiotherapy , Adult , Biomarkers/blood , Carcinoma, Papillary/surgery , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Iodine Radioisotopes/therapeutic use , Lymphatic Metastasis , Male , Middle Aged , Neck Dissection , Neoplasm Staging , Prospective Studies , Radionuclide Imaging , Radiopharmaceuticals/therapeutic use , Retreatment , Risk Assessment/methods , Thymus Gland/diagnostic imaging , Thymus Gland/metabolism , Thyroglobulin/metabolism , Thyroid Neoplasms/surgery , Thyroidectomy , Whole-Body CountingABSTRACT
The follow-up of Differentiated Thyroid Cancer conventionally includes serum thyroglobulin and periodic Whole Body Scans. The uptake of 131-I in normal and pathological tissues different from metastatic thyroid cancer sites is a cause of false-positive scans. Among them, mediastinal uptake caused by thymic hyperplasia can be observed. The aim of the present study was to review a series of 573 patients with differentiated thyroid cancer treated with 131-I after surgery between 1992 and 2003 looking above all for those with mediastinal images resembling thymus. This evaluation is presented together with some hypotheses on the relationships between thymus and thyroid. Moreover, some considerations are made on the differential diagnosis between thymus and mediastinal tumour thyroid residues.
Subject(s)
Iodine Radioisotopes/therapeutic use , Mediastinum/diagnostic imaging , Radiopharmaceuticals/therapeutic use , Thymus Gland/diagnostic imaging , Thyroid Neoplasms/radiotherapy , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Adenocarcinoma, Follicular/radiotherapy , Adenocarcinoma, Follicular/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Papillary/radiotherapy , Carcinoma, Papillary/surgery , False Positive Reactions , Female , Humans , Hyperplasia , Male , Middle Aged , Radionuclide Imaging , Radiotherapy, Adjuvant , Retrospective Studies , Thymus Gland/pathology , Thyroid Neoplasms/surgery , Whole-Body CountingABSTRACT
Whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) positron emission tomography (PET) of a 54-year-old woman with a history of recurrent thyroid follicular cancer and an elevated thyroglobulin level showed significant FDG uptake in the thyroid bed and anterior mediastinum. A previous scan after high-dose I-131 therapy also showed iodine uptake in these regions. Because of a lack of response to iodine therapy, the patient had surgery. Recurrent thyroid cancer was found in the neck, but the mediastinal lesion was shown to consist of normal thymus tissue. In repeated examinations performed after surgery, there was no uptake of FDG or I-131 in the anterior mediastinum. Previous treatment with a high dose of radioiodine may have contributed to visualization of a normal adult thymus with FDG PET.
Subject(s)
Fluorodeoxyglucose F18 , Radiopharmaceuticals , Thymus Gland/diagnostic imaging , Tomography, Emission-Computed , Adenocarcinoma, Follicular/diagnostic imaging , Adenocarcinoma, Follicular/radiotherapy , Female , Humans , Iodine Radioisotopes/therapeutic use , Middle Aged , Neoplasm Recurrence, Local/diagnostic imaging , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/radiotherapyABSTRACT
Protein-energy malnutrition decreases cellular immunity yet immune recovery has rarely been investigated during nutritional rehabilitation. Malnourished children from low income families of Cochabamba (Bolivia) were hospitalized for 2 months in the Center for Immune and Nutritional Rehabilitation (CRIN), of the German Urquidi Materno-Infantil Hospital. They received a special four-step diet. Nutritional status was determined by a daily clinical examination and weekly anthropometric measurements. Immune status was assessed by weekly ultrasonography of the thymus. The classical criterion for discharge (90 per cent of median reference weight for height) was reached after the first month, whereas a 2-month period was required for complete immunologic recovery. The children belonged to disadvantaged population groups with high exposure to disease. In such an environment, discharge based only on nutritional status after 1 month of treatment could explain frequent relapses because the children were still immunodepressed.
Subject(s)
Protein-Energy Malnutrition/diet therapy , Protein-Energy Malnutrition/immunology , Anthropometry , Bolivia , Female , Humans , Immunity, Cellular , Infant , Male , Nutritional Status , Thymus Gland/diagnostic imaging , UltrasonographyABSTRACT
Using 75Se methionine the authors performed a scintigraphic examination of the thymus in 65 patients, 15 of whom were suffering from myasthenia and 48 (control) from various neoplastic pathologies of the thyroid and the larynx. The examination has made it possible to discover parts of the thymus active tissue including those remaining after thymectomy. The method enables one to control the results of radiation and surgical treatment of myasthenic patients.